Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Rocky Mountain Poison & Drug Center, Denver, CO, USA.
Clin Toxicol (Phila). 2020 Jun;58(6):453-459. doi: 10.1080/15563650.2019.1657582. Epub 2019 Sep 16.
Cannabis (MJ) policy liberalization in a majority of US states has impacted emergency department (ED) visits. It is important to understand why people come to the ED after using MJ because the drug is now available to experienced and naïve people across the country. The objectives of this study were to (1) improve upon administrative dataset methodology by performing additional chart review to describe ED visits related to cannabis, (2) understand why patients come to the ED after using cannabis, and (3) begin to inform our understanding of cannabis-attributable ED visits to start to educate patients and providers about cannabis' safety. We performed a retrospective chart review of ED visits identified by cannabis ICD-9 and 10-CM codes between 2012 and 2016. Visits were reviewed and determined if the visit was partially attributable to cannabis based upon a pre-specified definition, then categorized into clinical complaint categories. Descriptive statistics, Chi-Square, and T-tests were used to elucidate the data. About one-fourth (25.74%) of visits with cannabis ICD-CM codes were found to be at least partially attributable to cannabis. These patients are more often young, Caucasian males when compared to the overall ED population ( < .0001). Patients with a cannabis-attributable visit were more often admitted to the hospital ( < .0001). The most common complaints in cannabis-attributable visits were gastrointestinal and psychiatric complaints, as well as intoxication. The number of cannabis-attributable visits rose with time (=.012). Based on a pre-specified definition, with good inter-rater reliability, we found that 25% of visits with a cannabis ICD-CM code were partially attributable to cannabis. These findings represent areas to target in cannabis user education as public perceptions change across time.
美国大多数州的大麻(MJ)政策自由化已经对急诊部(ED)的就诊量产生了影响。了解人们在使用大麻后为何会到 ED 就诊非常重要,因为这种药物现在已经在全国范围内向有经验的人和无经验的人提供。本研究的目的是:(1)通过进行额外的图表审查来改进行政数据集方法,以描述与大麻相关的 ED 就诊情况;(2)了解患者在使用大麻后为何会到 ED 就诊;(3)开始了解大麻引起的 ED 就诊,以开始向患者和提供者宣传大麻的安全性。我们对 2012 年至 2016 年间通过大麻 ICD-9 和 10-CM 代码识别的 ED 就诊情况进行了回顾性图表审查。根据预先规定的定义对就诊情况进行了审查,并确定就诊是否至少部分归因于大麻,然后将其分类为临床投诉类别。使用描述性统计、卡方检验和 t 检验来阐明数据。约四分之一(25.74%)的大麻 ICD-CM 代码就诊情况至少部分归因于大麻。与整体 ED 人群相比,这些患者更年轻,更常为白人男性(<0.0001)。归因于大麻的就诊患者更常被收治入院(<0.0001)。在归因于大麻的就诊中,最常见的投诉是胃肠道和精神科投诉,以及中毒。归因于大麻的就诊数量随时间增加(=0.012)。根据预先规定的定义,我们发现具有大麻 ICD-CM 代码的就诊中有 25%至少部分归因于大麻,具有良好的组内一致性。这些发现代表了随着时间的推移,在公共认知变化的情况下,在大麻使用者教育中需要针对的领域。